Variants in folate pathway genes as modulators of genetic instability and lung cancer risk

Genes Chromosomes and Cancer

Volumn 50, Issue 1, 2011, Pages 1-12

  Piskac Collier, Amanda L ^a   Monroy, Claudia ^a   Lopez, Mirtha S ^a   Cortes, Andrea ^a   Etzel, Carol J ^a   Greisinger, Anthony J ^b   Spitz, Margaret R ^a   El Zein, Randa A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Kelsey Seybold Research Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; FOLIC ACID;

ADULT; ALLELE; ARTICLE; CANCER PATIENT; CANCER RISK; CONTROL GROUP; CONTROLLED STUDY; CYTOKINESIS; DNA METHYLATION; FEMALE; FOLIC ACID BLOOD LEVEL; GENE INTERACTION; GENETIC POLYMORPHISM; GENETIC STABILITY; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HUMAN; LUNG CANCER; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MICRONUCLEUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

AGED; CASE-CONTROL STUDIES; FEMALE; FERREDOXIN-NADP REDUCTASE; FOLIC ACID; GENE REGULATORY NETWORKS; GENETIC PREDISPOSITION TO DISEASE; GENOMIC INSTABILITY; GLYCINE HYDROXYMETHYLTRANSFERASE; HUMANS; LINKAGE DISEQUILIBRIUM; LUNG NEOPLASMS; MALE; METABOLIC NETWORKS AND PATHWAYS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MICRONUCLEUS TESTS; MIDDLE AGED; ODDS RATIO; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; REGRESSION ANALYSIS; TUMOR CELLS, CULTURED;

NICOTIANA TABACUM;

EID: 78249284040     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20826     Document Type: Article

References (65)

1. 399Gln polymorphism in the DNA repair gene XRCC1 modulates the genotoxic response induced in human lymphocytes by the tobacco-specific nitrosamine NNK. Cancer Lett 159: 63-71.
2. Akopyan G, Bonavida B. 2006. Understanding tobacco smoke carcinogen NNK and lung tumorigenesis. Int J Oncol 29: 745-752.
3. American Cancer Society, Inc. 2009. Cancer Facts and Figures. Atlanta (GA): American Cancer Society.
4. Andreassi MG, Botto N, Cooci F, Battaglia D, Antonioli E, Masetti S, Manfredi S, Colombo MG, Biagini A, Clerico A. 2003. Methylenetetrahydrofolate reductase gene C677T polymorphism, homocysteine, vitamin B12, and DNA damage in coronary artery disease. Hum Genet 112: 171-177.
5. Beetstra S, Salisbury C, Turner J, Altree M, McKinnon R, Suthers G, Fenech M. 2006. Lymphocytes of BRCA1 and BRCA2 germ-line mutation carriers, with or without breast cancer, are not abnormally sensitive to the chromosome damaging effect of moderate folate deficiency. Carcinogenesis 27: 517-524.
6. Blount BC, Mack MM, Wehr CM, MacGregor JT, Hiatt RA, Wang G, Wickramasinghe SN, Everson RB, Ames BN. 1997. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: Implications for cancer and neuronal damage. Proc Natl Acad Sci 94: 3290-3295.
7. Boccia S, Boffetta P, Brennan P, Ricciardi G, Gianfagna F, Matsuo K, van Duijn CM, Hung RJ. 2009. Meta-analyses of the methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and risk of head and neck and lung cancer. Cancer Lett 273: 55-61.
8. Bonassi S, Ugolini D, Kirsch-Volders M, Strömberg U, Vermeulen R, Tucker JD. 2005. Human population studies with cytogenetic biomarkers: Review of the literature and future prospective. Environ Mol Mutagen 45: 258-270.
9. Botto N, Andreassi MG, Manfredi S, Masseti S, Cocci F, Colombo MG, Storti S, Rizza A, Biagi A. 2003. Genetic polymorphisms in folate and homocysteine metabolism as risk factors for DNA damage. Eur J Hum Genet 11: 671-678.
10. Breiman L, Friedman JN, Olsen RA, Stone CJ. 1984. Classification and Regression Trees. Monterey: Wadsworth and Brooks/Cole.
11. Candito M, Rivet R, Herbeth B, Boisson C, Rudigoz RC, Luton D, Journel H, Oury JF, Roux F, Saura R, Vernhet I, Gaucherand P, Muller F, Guidicelli B, Heckenroth H, Poulain P, Blayau M, Francannet C, Roszyk L, Brustié C, Staccini P, Gérard P, Fillion-Emery N, Guéant-Rodriguez RM, Van Obberghen E, Guéant JL. 2008. Nutritional and genetic determinants of vitamin B and homocysteine metabolisms in neural tube defects: A multicenter case-control study. Am J Med Genet A 146A: 1128-1133.
12. Chang S-C, Lin P-C, Lin J-K, Yang S-H, Wang H-S, Li AF-Y. 2007. Role of MTHFR polymorphisms and folate levels in different phenotypes of sporadic colorectal cancers. Int J Colorectal Dis 22: 483-489.
13. Chen J, Kyte C, Valcin M, Chan W, Wetmur JG, Selhub J, Hunter DJ, Ma J. 2004. Polymorphisms in the one-carbon metabolic pathway, plasma folate levels and colorectal cancer in a prospective study. Int J Cancer 110: 617-620.
14. Choi S-W, Mason J. 2000. Folate and carcinogenesis: An integrated scheme. Am Soc Nutrit Sci 130: 129-132.
15. Collin SM, Metcalfe C, Zuccolo L, Lewis SJ, Chen L, Cox A, Davis M, Lane JA, Donovan J, Smith GD, Neal DE, Hamdy FC, Gudmundsson J, Sulem P, Rafnar T, Benediktsdottir KR, Eeles RA, Guy M, Kote-Jarai Z; UK Genetic Prostate Cancer Study Group, Morrison J, Al Olama AA, Stefansson K, Easton DF, Martin RM. 2009. Association of folate-pathway gene polymorphisms with the risk of prostate cancer: A population-based nested case-control study, systematic review, and meta-analysis. Cancer Epidemiol Biomarkers Prev 18: 2528-2539.
16. Crott JW, Mashiyama ST, Ames BN, Fenech M. 2001. The effect of folic acid deficiency and MTHFR C677T polymorphism on chromosome damage in human lymphocytes in vitro. Cancer Epidemiol Biomarkers Prev 10: 1089-1096.
17. Dhillon V, Thomas P, Fenech M. 2009. Effect of common polymorphisms in folate uptake and metabolism genes on frequency of micronucleated lymphocytes in a South Australian cohort. Mutat Res 665: 1-6.
18. Duan H, Leng S, Pan Z, Dai Y, Niu Y, Huang C, Bin P, Wang Y, Liu Q, Chen W, Zheng Y. 2009. Biomarkers measured by cytokinesis-block micronucleus cytome assay for evaluating genetic damages induced by polycyclic aromatic hydrocarbons. Mutat Res 677: 93-99.
19. El-Zein RA, Schabath MB, Etzel CJ, Lopez MS, Franklin JD, Spitz MR. 2006. Cytokinesis-blocked micronucleus assay as a novel biomarker for lung cancer risk. Cancer Res 66: 6449-6456.
20. El-Zein RA, Fenech M, Lopez MS, Spitz MR, Etzel CJ. 2008. Cytokinesis-blocked micronucleus cytome assay biomarkers identify lung cancer cases among smokers. Cancer Epidemiol Biomarkers Prev 5: 1111-1119.
21. Fenech M. 2001. The role of folic acid and vitamin B12 in genomic instability of human cells. Mutat Res 475: 57-67.
22. Fenech M. 2002. Chromosomal biomarkers of genomic instability relevant to cancer. Drug Discov Today 7: 1128-1136.
23. Fenech M. 2006. Cytokinesis-block micronucleus assay evolves into a "cytome" assay of chromosomal instability, mitotic dysfunction and cell death. Mutat Res 600: 58-66.
24. Fenech M. 2008. The micronucleus assay determination of chromosomal level DNA damage. Methods Mol Biol 410: 185-216.
25. Fenech M, Crott JW. 2002. Micronuclei, nucleoplasmic bridges and nuclear buds induced in folic acid deficient human lymphocytes-evidence for breakage-fusion-bridge cycles in the cytokinesis-block micronucleus assay. Mutat Res 504: 131-136.
26. Fenech M, Morley AA. 1985. Measurement of micronuclei in lymphocytes. Mutat Res 147: 29-36.
27. Fenech M, Chang WP, Kirsch-Volders M, Holland N, Bonassi S, Zeiger E. 2003. HUMN Project: Detailed description of the scoring criteria for the cytokinesis-blocked micronucleus assay using isolated human lymphocyte cultures. Mutat Res 53: 65-75.
28. Ferguson LR, Philpott M. 2008. Nutrition and mutagenesis. Annu Rev Nutr 28: 313-329.
29. Fraga MF, Herranz M, Espada J, Ballestar E, Paz MF, Ropero S, Erkek E, Bozdogan O, Peinado H, Niveleau A, Mao JH, Balmain A, Cano A, Esteller M. 2004. A mouse skin multistage carcinogenesis model reflects the aberrant DNA methylation patterns of human tumors. Cancer Res 64: 5527-5534.
30. Friso S, Choi S-W, Girelli D, Mason, J, Dolnikowski GD, Bagley, PJ, Oliveri O, Jacques PF, Rosenberg IH, Corrocher R, Selhub J. 2002. A common mutation in the 5, 10-methelenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc Nalt Acad Sci 99: 5606-5611.
31. Gemmati D, Ongaro A, Scapoli GL, Della Porta M, Tognazzo S, Serino ML, Di Bona E, Rodeghiero F, Gilli G, Reverberi R, Caruso A, Pasello M, Pellati A, De Mattei M. 2004. Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin's lymphoma in adults. Cancer Epidemiol Biomarkers Prev 13: 787-794.
32. Hagmar L, Strömberg U, Tinnerberg H, Mikoczy Z. 2004. Epidemiological evaluation of cytogenetic biomarkers as potential surrogate end-points for cancer. IARC Sci Publ 157: 207-215.
33. Hahn LW, Ritchie MD, Moore JH. 2003. Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics 19: 376-382.
34. Hazra A, Selhub J, Chao WH, Ueland PM, Hunter DJ, Baron JA. 2010. Uracil misincorporation into DNA and folic acid supplementation. Am J Clin Nutr 91: 160-165.
35. Hecht SS. 1999. DNA adduct formation from tobacco-specific N-nitrosamines. Mutat Res 424: 127-142.
36. 241 Met polymorphism in the XRCC3 gene. Environ Mol Mutagen 46: 22-29.
37. Hishida A, Matsuo K, Hamajima N, Ito H, Ogura M, Kagami Y, Taji H, Morishima Y, Emi N, Tajima K. 2003. Associations between polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and susceptibility to malignant lymphoma. Haematologica 88: 159-166.
38. Iarmarcovai G, Bonassi S, Botta A, Baan RA, Orsiére T. 2008. Genetic polymorphisms and micronucleus formation: A review of the literature. Mutat Res 658: 215-233.
39. Imanishi H, Okamura N, Yagi M, Noro Y, Moriya Y, Nakamura T, Hayakawa A, Takeshima Y, Sakaeda T, Matsuo M, Okumura K. 2007. Genetic polymorphisms associated with adverse events and elimination of methotrexate in childhood acute lymphoblastic leukemia and malignant lymphoma. J Hum Genet 52: 166-171.
40. Le Marchand L, Donlon T, Hankin JH, Kolonel LN, Wilkens LR, Seifried A. 2002. B-vitamin intake, metabolic genes, and colorectal cancer risk (United States). Cancer Causes Control 13: 239-248.
41. Leopardi P, Marcon F, Caiola S, Cafolla A, Siniscalchi E, Zijno A, Crebelli R. 2006. Effects of folic acid deficiency and MTHFR c677t polymorphism on spontaneous and radiation-induced micronuclei in human lymphocytes. Mutagenesis 21: 327-333.
42. Ma J, Stampfer MJ, Giovannucci E, Artigas C, Hunter DJ, Fuchs C, Willett WC, Selhub J, Hennekens CH, Rozen R. 1997. Methylenetetrahydrofolate reductase polymorphisms, dietary interactions, and risk of colorectal cancer. Cancer Res 57: 1098-1102.
43. Matakidou A, El Galta R, Rudd MF, Webb EL, Bridle H, Eisen T, Houlston RS. 2007. Prognostic significance of folate metabolism polymorphisms for lung cancer. Br J Cancer 97: 247-252.
44. Murtaugh MA, Curtin K, Sweeney C, Wolff RK, Holubkov R, Caan BJ, Slattery ML. 2007. Dietary intake of folate and co-factors in folate metabolism, MTHFR polymorphisms, and reduced rectal cancer. Cancer Causes Control 18: 153-163.
45. Ouerhani S, Rouissi K, Marrakchi R, Ben Slama MR, Sfaxi M, Chebil M, ElGaaied AB. 2009. Combined effect of NAT2, MTR, and MTHFR genotypes and tobacco on bladder cancer susceptibility in Tunisian population. Cancer Detect Prev 32: 395-402.
46. Petra BG, Janez J, Vita D. 2007. Gene-gene interactions in the folate metabolic pathway influence the risk for acute lymphoblastic leukemia in children. Leuk Lymph 48: 786-792.
47. Ritchie MD, Hahn LW, Roodi N, Bailey LR, Dupont WD, Parl FF, Moore JH. 2001. Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet 69: 138-147.
48. Schwahn B, Rozen R. 2001. Polymorphisms in the methylenetetrahydrofolate reductase gene: Clinical consequences. Am J Pharmacogenomics 3: 189-201.
49. Sharp L, Little J. 2004. Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: A HuGE review. Am J Epidemiol 159: 423-443.
50. Sheilds PG. 2002. Molecular epidemiology of smoking and lung cancer. Oncogene 21: 6870-6876.
51. Shi Q, Zhang Z, Li G, Pillow PC, Hernandez LM, Spitz MR, Wei Q. 2005. Polymorphisms of methionine synthase and methionine synthase reductase and risk of lung cancer: A case-control analysis. Pharmacogenet Genomics 15: 547-555.
52. Shih IeM, Davidson B. 2009. Pathogenesis of ovarian cancer: Clues from selected overexpressed genes. Future Oncol 5: 1641-1657.
53. Siemianowicz K, Gminski J, Garczorz W, Slabiak N, Goss M, Machalski M, Magiera-Molendowska H. 2003. Methylenetetrahydrofolate reductase gene C677T and A1298C polymorphism in patients with small cell and non-small cell lung cancer. Oncol Rep 10: 1341-1344.
54. Skibola CF, Smith MT, Hubbard A, Shane B, Roberts AC, Law GR, Rollinson S, Roman E, Cartwright RA, Morgan GJ. 2002. Polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and risk of adult acute lymphocytic leukemia. Blood 99: 3786-3791.
55. Spitz MR, Wei Q, Dong Q, Amos CI, Wu X. 2003. Genetic susceptibility to lung cancer: The role of DNA damage and repair. Cancer Epidemiol Biomarkers Prev 12: 689-698.
56. Stern-Lathrop L, Mason JB, Selhub J, Choi- S-W. 2000. Genomic DNA hypomethylation, a characteristic of most cancers, is present in peripheral leukocytes of individuals who are homozygous for the C677T polymorphism in the Methylenetetrahydrofolate reductase gene. Cancer Epidemiol Biomarkers Prev 9: 849-853.
57. Tanaka T, Scheet P, Giusti B, Bandinelli S, Piras MG, Usala G, Lai S, Mulas A, Corsi AM, Vestrini A, Sofi F, Gori AM, Abbate R, Guralnik J, Singleton A, Abecasis GR, Schlessinger D, Uda M, Ferrucci L. 2009. Genome-wide association study of vitamin B6, vitamin B12, folate, and homocysteine blood concentrations. Am J Hum Genet 4: 477-482.
58. Thomas P, Fenech M. 2008. Methylenetetrahydrofolate reductase, common polymorphisms, and relation to disease. Vitam Horm 79: 375-392.
59. Thun MJ, Lally CA, Flannery JT, Jr. 1997. Cigarette smoking and changes in the histopathology of lung cancer. JNCI 89: 1580-1586.
60. Vaissière T, Hung RJ, Zaridze D, Moukeria A, Cuenin C, Fasolo V, Ferro G, Paliwal A, Hainaut P, Brennan P, Tost J, Boffetta P, Herceg Z. 2009. Quantitative analysis of DNA methylation profiles in lung cancer identifies aberrant DNA methylation of specific genes and its association with gender and cancer risk factors. Cancer Res 69: 243-245.
61. Wang X, Thomas P, Xue J, Fenech M. 2004. Folate deficiency induces aneuploidy in human lymphocytes in vitro-evidence using cytokinesis-blocked cells and probes specific for chromosomes 17 and 21. Mutat Res 551: 167-180.
62. Wyatt MD, Pittman DL. 2006. Methylating agents and DNA repair responses: Methylated bases and sources of strand breaks. Chem Res Toxicol 12: 1580-1594.
63. Xu WH, Shrubsole MJ, Xiang YB, Cai Q, Zhao GM, Ruan ZX, Cheng JR, Zheng W, Shu XO. 2007. Dietary folate intake, MTHFR genetic polymorphisms, and the risk of endometrial cancer among Chinese women. Cancer Epidemiol Biomarkers Prev 16: 281-287.
64. Xu X, Chen J. 2009. One-carbon metabolism and breast cancer: An epidemiological perspective. J Genet Genomics 36: 203-214.
65. Zijno A, Andreoli C, Leopardi P, Marcon F, Rossi S, Caiola S, Verdina A, Galati R, Cafolla A, Crebelli R. 2003. Folate status, metabolic genotype, and biomarkers of genotoxicity in healthy subjects. Carcinogenesis 24: 1097-1103.